Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus replication

被引:48
作者
Pantry, Shara N. [1 ]
Medveczky, Peter G. [1 ]
机构
[1] Univ S Florida, Dept Mol Med, Coll Med, Tampa, FL 33612 USA
关键词
Kaposi's sarcoma-associated herpesvirus; Epigenetics; Histone acetylation; Chromatin structure; DNA methylation; CREB-BINDING PROTEIN; OPEN READING FRAME-50; NUCLEAR ANTIGEN; K-BZIP; TRANSCRIPTIONAL ACTIVITY; RESPONSE ELEMENT; DNA-SEQUENCES; LATENCY; KSHV; REACTIVATION;
D O I
10.1016/j.semcancer.2009.02.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Kaposi's sarcoma-associated herpesvirus (KSHV) is the causative agent of Kaposi's sarcoma and B-lymphocyte disorders, primary effusion lymphoma (PEL) and Multicentric Castleman's Disease (MCD). KSHV usually exists in a latent form in which the viral genome is circularized into an extrachormosomal episome. However, induction of lytic replication by environmental stimuli or chemical agents is important for the spread of KSHV. The switch between latency and lytic replication is regulated by epigenetic factors. Hypomethylation of the promoter of replication and transcription activator (RTA), which is essential for the lytic switch, leads to KSHV reactivation. Histone acetylation induces KSHV replication by influencing protein-protein-associations and transcription factor binding. Histone modifications also determine chromatin structure and nucleosome positioning, which are important for KSHV DNA replication during latency. The association of KSHV proteins with chromatin remodeling complexes promotes the open chromatin structure needed for transcription factor binding and DNA replication. Additionally, post-translational modification of KSHV proteins is important for the regulation of RTA activity and KSHV replication. KSHV may also cause epigenetic modification of the host genome, contributing to promoter hypermethylation of tumor suppressor genes in KSHV-associated neoplasias. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:153 / 157
页数:5
相关论文
共 47 条
[1]   Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen [J].
Ballestas, ME ;
Chatis, PA ;
Kaye, KM .
SCIENCE, 1999, 284 (5414) :641-644
[2]   Epigenetic and chromatin modifiers as targeted therapy of hematologic malignancies [J].
Bhalla, KN .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (17) :3971-3993
[3]   KAPOSIS SARCOMA-ASSOCIATED HERPESVIRUS-LIKE DNA-SEQUENCES IN AIDS-RELATED BODY-CAVITY-BASED LYMPHOMAS [J].
CESARMAN, E ;
CHANG, Y ;
MOORE, PS ;
SAID, JW ;
KNOWLES, DM .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (18) :1186-1191
[4]   IDENTIFICATION OF HERPESVIRUS-LIKE DNA-SEQUENCES IN AIDS-ASSOCIATED KAPOSIS-SARCOMA [J].
CHANG, Y ;
CESARMAN, E ;
PESSIN, MS ;
LEE, F ;
CULPEPPER, J ;
KNOWLES, DM ;
MOORE, PS .
SCIENCE, 1994, 266 (5192) :1865-1869
[5]   Activation of latent Kaposi's sarcoma-associated herpesvirus by demethylation of the promoter of the lytic transactivator [J].
Chen, J ;
Ueda, K ;
Sakakibara, S ;
Okuno, T ;
Parravicini, C ;
Corbellino, M ;
Yamanishi, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (07) :4119-4124
[6]   DNA tumor viruses and human cancer [J].
Damania, Blossom .
TRENDS IN MICROBIOLOGY, 2007, 15 (01) :38-44
[7]   The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients [J].
Decker, LL ;
Shankar, P ;
Khan, G ;
Freeman, RB ;
Dezube, BJ ;
Lieberman, J ;
ThorleyLawson, DA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (01) :283-288
[8]   KSHV LANA inhibits TGF-β signaling through epigenetic silencing of the TGF-β type II receptor [J].
Di Bartolo, Daniel L. ;
Cannon, Mark ;
Liu, Yi-Fang ;
Renne, Rolf ;
Chadburn, Amy ;
Boshoff, Chris ;
Cesarman, Ethel .
BLOOD, 2008, 111 (09) :4731-4740
[9]   Latency-associated nuclear antigen (LANA) cooperatively binds to two sites within the terminal repeat, and both sites contribute to the ability of LANA to suppress transcription and to facilitate DNA replication [J].
Garber, AC ;
Hu, JH ;
Renne, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (30) :27401-27411
[10]   Epigenetic changes in cancer [J].
Gronbaek, Kirsten ;
Hother, Christoffer ;
Jones, Peter A. .
APMIS, 2007, 115 (10) :1039-1059